TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18727647

Group type: EXPERIMENTAL
Intervention: Drug and behavioural therapy for acute headache treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Invasive procedures (injections)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral drugs
Number of subjects: 0
Study: 16834790

Group type: EXPERIMENTAL
Intervention: High volume (60 mL of anaesthetic solution)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low volume (30 mL of anaesthetic solution)
Number of subjects: 60
Study: 15568952

Group type: EXPERIMENTAL
Intervention: Handheld polarized light camera (USB camera)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 16-bit electronically cooled camera
Number of subjects: 0
Study: 10743462

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine with epinephrine 1:200,000
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% normal saline
Number of subjects: 40
Study: 9199943

Group type: EXPERIMENTAL
Intervention: Bamiphylline (300 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 16
Study: 1287196

Group type: EXPERIMENTAL
Intervention: Two prototypical ethanol-water flux-enhanced transdermal therapeutic systems
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Prototype B
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Prototype A
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Both prototypes
Number of subjects: 6

Group type: COMPARATOR
Intervention: Transderm-Nitro 10
Number of subjects: 6
Study: 4005127

Group type: EXPERIMENTAL
Intervention: Oros system with initial release rate of 14 mg/h
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oros system with initial release rate of 19 mg/h
Number of subjects: 6
Study: 3589362

Group type: EXPERIMENTAL
Intervention: Gestagen therapy (lynestrenol)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Phytotherapy (Mastodynon)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 29401266

Group type: EXPERIMENTAL
Intervention: CE-SAV
Number of subjects: 394

Group type: COMPARATOR
Intervention: Mosaic
Number of subjects: 394
Study: 26962903

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (320 mg and 1600 mg, respectively, twice daily for 7 days)
Number of subjects: 1247

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1247

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 1247
Study: 25071367

Group type: EXPERIMENTAL
Intervention: PEA/AEA emollient
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional emollient
Number of subjects: 60
Study: 21982391

Group type: EXPERIMENTAL
Intervention: Single-row rotator cuff repair
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Double-row rotator cuff repair
Number of subjects: 53

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 53
Study: 20858114

Group type: EXPERIMENTAL
Intervention: 4 mg triamcinolone acetonide monotherapy (n=17)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 1.25 mg bevacizumab monotherapy (n=14)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Combination of 2 mg triamcinolone acetonide and 1.25 mg bevacizumab (n=21)
Number of subjects: 52
Study: 18178372

Group type: EXPERIMENTAL
Intervention: Trail Making Test B (TMT B)
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Diagnostic classification accuracy
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Trail Making Test A (TMT A)
Number of subjects: 526
Study: 16139963

Group type: EXPERIMENTAL
Intervention: Project EX smoking cessation clinic
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 15931282

Group type: EXPERIMENTAL
Intervention: Iron supplementation (60 mg/day elemental iron)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10683053

Group type: EXPERIMENTAL
Intervention: Critical pathway intervention (n = 9 hospitals)
Number of subjects: 1743

Group type: COMPARATOR
Intervention: Conventional management (n = 10 hospitals)
Number of subjects: 1743
Study: 9100599

Group type: EXPERIMENTAL
Intervention: m-chlorophenylpiperazine (m-CPP) 0.5 mg/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: m-chlorophenylpiperazine (m-CPP)
Number of subjects: 20
Study: 8096880

Group type: EXPERIMENTAL
Intervention: Fenoterol 0.4 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 0.2 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 2879736

Group type: EXPERIMENTAL
Intervention: Loratadine (160 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Chlorpheniramine maleate (4 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31101018

Group type: EXPERIMENTAL
Intervention: 6 times per week hemodialysis
Number of subjects: 44

Group type: COMPARATOR
Intervention: 3 times per week hemodialysis
Number of subjects: 44
Study: 29498049

Group type: EXPERIMENTAL
Intervention: Amustaline-treated RBCs
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional RBCs (control)
Number of subjects: 51
Study: 26656773

Group type: EXPERIMENTAL
Intervention: BFR + N (narrow cuff, 5 cm)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: BFR + W (wide cuff, 10 cm)
Number of subjects: 11
Study: 25351118

Group type: EXPERIMENTAL
Intervention: Laryngeal tumor biopsies in NBI mode (Group B)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Laryngeal tumor biopsies in white light mode (Group A)
Number of subjects: 113
Study: 22998983

Group type: EXPERIMENTAL
Intervention: Individual Cognitive Stimulation Therapy (iCST) sessions delivered by a carer for 30 minutes, 3 times a week over 25 weeks
Number of subjects: 306

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 306
Study: 20543737

Group type: EXPERIMENTAL
Intervention: Unloaded dynamic squats with WBV (45 Hz)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Loaded dynamic squats without WBV (30% of body mass)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Loaded dynamic squats with WBV (45 Hz)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Unloaded dynamic squats without WBV
Number of subjects: 13
Study: 18212032

Group type: EXPERIMENTAL
Intervention: Rhythmic stabilization
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Rhythmic stabilization - TENS
Number of subjects: 92

Group type: COMPARATOR
Intervention: TENS
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 16156943

Group type: EXPERIMENTAL
Intervention: Mammographic screening
Number of subjects: 0
Study: 11810078

Group type: EXPERIMENTAL
Intervention: 20-cm² patch (Ortho Evra)
Number of subjects: 610

Group type: COMPARATOR
Intervention: Ortho-Cyclen
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: All patch regimens
Number of subjects: 610
Study: 10935771

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control (Ctr)
Number of subjects: 37
Study: 8959872

Group type: EXPERIMENTAL
Intervention: CsA monotherapy
Number of subjects: 122

Group type: COMPARATOR
Intervention: Conversion from CsA to azathioprine
Number of subjects: 122
Study: 1283730

Group type: EXPERIMENTAL
Intervention: IGF-I (40 micrograms/kg by single subcutaneous dose)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 4025678

Group type: EXPERIMENTAL
Intervention: Modified contract-relax (CR) method, trained three times a week for 30 days (14 training sessions)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Traditional ballistic stretch (BS) method, trained during the same time for 30 days
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Training frequency of once a week for 30 days after initial training
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Training frequency of three times a week for 30 days after initial training
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Training frequency of five times a week for 30 days after initial training
Number of subjects: 47
Study: 30043192

Group type: EXPERIMENTAL
Intervention: Home-based sensory interventions plus standard therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard therapy (speech therapy and applied behavior analysis)
Number of subjects: 40
Study: 28009070

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 26106946

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon
Number of subjects: 476

Group type: COMPARATOR
Intervention: Standard angioplasty
Number of subjects: 476
Study: 22964975

Group type: EXPERIMENTAL
Intervention: Pioglitazone (15 mg/day) for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 22097160

Group type: EXPERIMENTAL
Intervention: Multi-drug injection (ropivacaine, morphine, ketorolac, and epinephrine)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Multi-drug injection
Number of subjects: 30
Study: 19213683

Group type: EXPERIMENTAL
Intervention: Financial incentives for smoking cessation (including $100 for program completion, $250 for cessation within 6 months, and $400 for abstinence for an additional 6 months)
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Financial incentives for smoking cessation
Number of subjects: 878
Study: 16967054

Group type: EXPERIMENTAL
Intervention: Brief nurse-delivered intervention
Number of subjects: 105

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 105
Study: 12720237

Group type: EXPERIMENTAL
Intervention: Transradial intervention (TRI)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Transfemoral intervention (TFI)
Number of subjects: 149
Study: 10966889

Group type: EXPERIMENTAL
Intervention: Fish oil (providing 2.0 g EPA/d and 1.4 g DHA/d)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sunflower oil (providing 12.3 g oleate/d)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Safflower oil (providing 10.5 g linoleate/d)
Number of subjects: 15
Study: 9201636

Group type: COMPARATOR
Intervention: Static stretch (30 seconds, twice daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Active stretch (30 repetitions of active knee extension while sitting in a neural slump position, twice daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 8431573

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2887723

Group type: EXPERIMENTAL
Intervention: Social-work services for six months
Number of subjects: 345

Group type: COMPARATOR
Intervention: Control group (no social-work services)
Number of subjects: 345
Study: 31149747

Group type: EXPERIMENTAL
Intervention: Functional capacity assessment using the Barthel Index, Lawton and Brody Scale, Evaluation Form of Dependence in Self-care, Self-care of Home Dwelling Elderly (self-care subscale profiles)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Monitoring of functional capacity and self-care profile
Number of subjects: 313
Study: 30019970

Group type: EXPERIMENTAL
Intervention: 755-nm picosecond pulsed alexandrite laser treatments (4 treatments, spaced 3 weeks apart)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 1927-nm fractionated thulium laser treatments (2 treatments, spaced 6 weeks apart)
Number of subjects: 20
Study: 27802253

Group type: EXPERIMENTAL
Intervention: Early intervention (outpatient, intensive back school)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 58
Study: 26678633

Group type: EXPERIMENTAL
Intervention: Intralesion abciximab
Number of subjects: 128

Group type: COMPARATOR
Intervention: Intracoronary abciximab
Number of subjects: 128

Group type: COMPARATOR
Intervention: Aspiration thrombectomy
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: No aspiration thrombectomy
Number of subjects: 128
Study: 24283160

Group type: EXPERIMENTAL
Intervention: Red clover isoflavones supplementation (60.8 mg red clover isoflavones plus 19.2 mg soy isoflavones)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 21596867

Group type: EXPERIMENTAL
Intervention: 15 mL of autologous blood
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 20 mL of autologous blood
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 30 mL of autologous blood
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 121
Study: 18444850

Group type: EXPERIMENTAL
Intervention: Clarithromycin (1 g, intravenously once daily for 3 consecutive days)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 17547070

Group type: EXPERIMENTAL
Intervention: Vaccinated group
Number of subjects: 1039

Group type: COMPARATOR
Intervention: Non-vaccinated group
Number of subjects: 1039

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 1039
Study: 14517188

Group type: COMPARATOR
Intervention: Unpurged high-dose therapy (U)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Purged high-dose therapy (P)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Standard treatment (C)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control (C) vs Unpurged + Purged (U + P)
Number of subjects: 140
Study: 11156078

Group type: EXPERIMENTAL
Intervention: Bovine pericardium for buttressing (Peri-Strips Dry; Bio‐Vascular, Inc, Saint Paul, MN)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (without bovine pericardium)
Number of subjects: 65
Study: 9094873

Group type: COMPARATOR
Intervention: Iron-fortified, cow milk-based infant formula (465 mg Ca and 317 mg P/L)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Iron-fortified infant formula with added calcium glycerophosphate (1800 mg Ca and 1390 mg P/L)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Both groups (control and supplemented)
Number of subjects: 103
Study: 7524255

Group type: EXPERIMENTAL
Intervention: 6% HES with Mw of 450,000 dalton and MS of 0.7
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 6% HES with Mw of 200,000 dalton and MS of 0.5
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 6% HES with Mw of 200,000 dalton and MS of 0.62
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 6% HES with Mw of 40,000 dalton and MS of 0.5
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group without ANH (10 patients)
Number of subjects: 40
Study: 2685988

Group type: EXPERIMENTAL
Intervention: Cefadroxil
Number of subjects: 22

Group type: COMPARATOR
Intervention: Metronidazole
Number of subjects: 22
Study: 1098751

Group type: EXPERIMENTAL
Intervention: Althesin (0.05 ml/kg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 200
Study: 30342394

Group type: EXPERIMENTAL
Intervention: FLZ tablets, administered orally, dosage not specified, duration not specified
Number of subjects: 0
Study: 29164255

Group type: EXPERIMENTAL
Intervention: Indwelling pleural catheter
Number of subjects: 146

Group type: COMPARATOR
Intervention: Talc pleurodesis
Number of subjects: 146
Study: 25960085

Group type: EXPERIMENTAL
Intervention: riluzole plus mexiletine 300 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: riluzole 100 mg
Number of subjects: 60
Study: 23608562

Group type: EXPERIMENTAL
Intervention: Brief psychosocial education program (PSEP)
Number of subjects: 4295

Group type: COMPARATOR
Intervention: Not receiving psychosocial education
Number of subjects: 4295
Study: 23013045

Group type: EXPERIMENTAL
Intervention: Pennebaker's emotional writing intervention
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 202
Study: 19607949

Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine (IVV) with 1 million units (Mu) of alpha interferon
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine (IVV) with 10 million units (Mu) of alpha interferon
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trivalent inactivated influenza vaccine (IVV) alone
Number of subjects: 0
Study: 17885853

Group type: EXPERIMENTAL
Intervention: Intranasal ciclesonide 200 micro g once daily
Number of subjects: 150

Group type: COMPARATOR
Intervention: Inhaled fluticasone propionate-salmeterol (FP-SAL) 500 to 50 micro g twice daily
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Dexamethasone 2 mg single dose
Number of subjects: 150
Study: 15236630

Group type: EXPERIMENTAL
Intervention: Roxil (500 mg capsule)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ultracef (500 mg capsule)
Number of subjects: 24
Study: 12133499

Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS), given once a day for 14 days.
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS), given once a day for 14 days, in subgroup aged 35-55.
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS), given once a day for 14 days, in subgroup aged 56-75.
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS), given once a day for 14 days, in subgroup aged over 75.
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS), given once a day for 14 days, in subgroup with early TMS treatment.
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS), given once a day for 14 days, in subgroup with TMS beginning 3 months after onset.
Number of subjects: 223

Group type: COMPARATOR
Intervention: Control group (no TMS), basic treatment same as TMS group.
Number of subjects: 223
Study: 9822239

Group type: EXPERIMENTAL
Intervention: 0.25% fluorometholone eyedrops four times daily before and after argon laser trabeculoplasty
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo eyedrops four times daily before and after argon laser trabeculoplasty
Number of subjects: 27
Study: 7484996

Group type: EXPERIMENTAL
Intervention: Combined bile acid therapy (chenodeoxycholic acid 500 mg/day and ursodeoxycholic acid 500 mg/day)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Ursodeoxycholic acid alone (1000 mg/day)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Combined bile acid therapy
Number of subjects: 104

Group type: COMPARATOR
Intervention: Ursodeoxycholic acid alone
Number of subjects: 104
Study: 2143369

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Etodolac
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 27
Study: 7443776

Group type: EXPERIMENTAL
Intervention: Lithium salts
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Lithium salts with concomitant antidepressive medication (moderate doses for 4 weeks)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Only lithium
Number of subjects: 17
Study: 31782181

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) - 0.5g/kg on day 1, 1g/kg on day 2, 0.6g/kg on weeks 3 and 5
Number of subjects: 17

Group type: COMPARATOR
Intervention: Volume-matched intravenous normal saline (placebo)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Open-label IVIG arm
Number of subjects: 17
Study: 30730546

Group type: EXPERIMENTAL
Intervention: Laparoscopic distal gastrectomy
Number of subjects: 1416

Group type: COMPARATOR
Intervention: Open distal gastrectomy
Number of subjects: 1416
Study: 28562678

Group type: EXPERIMENTAL
Intervention: Default option (200g of pre-portioned vegetables)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Priming (leafy environment with green plants and odour of herbs)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Perceived variety (dividing pre-mixed salad into components)
Number of subjects: 88
Study: 26057085

Group type: EXPERIMENTAL
Intervention: 6% hydrogen peroxide bleaching agent
Number of subjects: 31

Group type: COMPARATOR
Intervention: 35% hydrogen peroxide bleaching agent
Number of subjects: 31
Study: 24037762

Group type: EXPERIMENTAL
Intervention: Generalized joint hypermobility (GJH)
Number of subjects: 75
Study: 20720454

Group type: EXPERIMENTAL
Intervention: HPA lanolin
Number of subjects: 84

Group type: COMPARATOR
Intervention: Expressed breastmilk (EBM)
Number of subjects: 84
Study: 19362318

Group type: EXPERIMENTAL
Intervention: Thrombus aspiration after primary percutaneous coronary intervention (PCI)
Number of subjects: 933
Study: 16390282

Group type: EXPERIMENTAL
Intervention: Constructive worry intervention (recording possible solutions to worries)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Worry group (recording worries and completing worry questionnaires)
Number of subjects: 33
Study: 12734132

Group type: EXPERIMENTAL
Intervention: EBT results with Intensive Case Management (ICM) (n = 111)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: EBT results with Usual Care (n = 119)
Number of subjects: 450

Group type: COMPARATOR
Intervention: EBT results withheld with Intensive Case Management (ICM) (n = 124)
Number of subjects: 450

Group type: COMPARATOR
Intervention: EBT results withheld with Usual Care (n = 96)
Number of subjects: 450
Study: 10682290

Group type: EXPERIMENTAL
Intervention: Causal-model theory
Number of subjects: 0

Group type: COMPARATOR
Intervention: Associative theories
Number of subjects: 0
Study: 1793675

Group type: EXPERIMENTAL
Intervention: oral oestradiol valerate in a cyclical combination with cyproterone acetate (n = 19)
Number of subjects: 36

Group type: COMPARATOR
Intervention: placebo (n = 17)
Number of subjects: 36
Study: 6422478

Group type: EXPERIMENTAL
Intervention: 400 mg fenoprofen calcium 3-times daily
Number of subjects: 77

Group type: COMPARATOR
Intervention: 250 mg naproxen sodium 3-times daily
Number of subjects: 77
Study: 30273507

Group type: EXPERIMENTAL
Intervention: Inflation factors method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incrementing method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bonferroni correction method
Number of subjects: 0
Study: 28735036

Group type: EXPERIMENTAL
Intervention: Proactive Care (proactive outreach plus connection to smoking cessation services)
Number of subjects: 5123

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 5123
Study: 27091525

Group type: EXPERIMENTAL
Intervention: Baseline log10(AHI+1)
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: SaO2 desaturation indices
Number of subjects: 601
Study: 24621960

Group type: EXPERIMENTAL
Intervention: L-citrulline (10 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (L-alanine)
Number of subjects: 10